BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 19825179)

  • 1. Distinct inherited metastasis susceptibility exists for different breast cancer subtypes: a prognosis study.
    Hsieh SM; Look MP; Sieuwerts AM; Foekens JA; Hunter KW
    Breast Cancer Res; 2009; 11(5):R75. PubMed ID: 19825179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The contribution of SIPA1 and RRP1B germline polymorphisms to breast cancer phenotype, lymph node status and survival in a group of Lithuanian young breast cancer patients.
    Ugenskienė R; Myrzaliyeva D; Jankauskaitė R; Gedminaitė J; Jančiauskienė R; Šepetauskienė E; Juozaitytė E
    Biomarkers; 2016; 21(4):363-70. PubMed ID: 26901824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphisms of the SIPA1 gene and sporadic breast cancer susceptibility.
    Hsieh SM; Smith RA; Lintell NA; Hunter KW; Griffiths LR
    BMC Cancer; 2009 Sep; 9():331. PubMed ID: 19765277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rrp1B gene polymorphism (1307T>C) in metastatic progression of breast cancer.
    Nanchari SR; Cingeetham A; Meka P; Damineni S; Tipirisetti N; Padala C; Annamaneni S; Rani Hanumanth S; Digumarthi RR; Satti V
    Tumour Biol; 2015 Feb; 36(2):615-21. PubMed ID: 25277657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Case-only analyses of the associations between polymorphisms in the metastasis-modifying genes BRMS1 and SIPA1 and breast tumor characteristics, lymph node metastasis, and survival.
    Roberts MR; Hong CC; Edge SB; Yao S; Bshara W; Higgins MJ; Freudenheim JL; Ambrosone CB
    Breast Cancer Res Treat; 2013 Jun; 139(3):873-85. PubMed ID: 23771732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rrp1b, a new candidate susceptibility gene for breast cancer progression and metastasis.
    Crawford NP; Qian X; Ziogas A; Papageorge AG; Boersma BJ; Walker RC; Lukes L; Rowe WL; Zhang J; Ambs S; Lowy DR; Anton-Culver H; Hunter KW
    PLoS Genet; 2007 Nov; 3(11):e214. PubMed ID: 18081427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Germline polymorphisms in SIPA1 are associated with metastasis and other indicators of poor prognosis in breast cancer.
    Crawford NP; Ziogas A; Peel DJ; Hess J; Anton-Culver H; Hunter KW
    Breast Cancer Res; 2006; 8(2):R16. PubMed ID: 16563182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of SIPA1 545 C > T polymorphism with survival in Chinese women with metastatic breast cancer.
    Pei R; Xu Y; Wei Y; Ouyang T; Li J; Wang T; Fan Z; Fan T; Lin B; Xie Y
    Front Med; 2013 Mar; 7(1):138-42. PubMed ID: 23358895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single nucleotide variants in metastasis-related genes are associated with breast cancer risk, by lymph node involvement and estrogen receptor status, in women with European and African ancestry.
    Roberts MR; Sucheston-Campbell LE; Zirpoli GR; Higgins M; Freudenheim JL; Bandera EV; Ambrosone CB; Yao S
    Mol Carcinog; 2017 Mar; 56(3):1000-1009. PubMed ID: 27597141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Germline polymorphisms are potential metastasis risk and prognosis markers in breast cancer.
    Hsieh SM; Lintell NA; Hunter KW
    Breast Dis; 2006-2007; 26():157-62. PubMed ID: 17473374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphisms in MMP9 and SIPA1 are associated with increased risk of nodal metastases in early-stage cervical cancer.
    Brooks R; Kizer N; Nguyen L; Jaishuen A; Wanat K; Nugent E; Grigsby P; Allsworth JE; Rader JS
    Gynecol Oncol; 2010 Mar; 116(3):539-43. PubMed ID: 19906411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic variation in SIPA1 in relation to breast cancer risk and survival after breast cancer diagnosis.
    Gaudet MM; Hunter K; Pharoah P; Dunning AM; Driver K; Lissowska J; Sherman M; Peplonska B; Brinton LA; Chanock S; Garcia-Closas M
    Int J Cancer; 2009 Apr; 124(7):1716-20. PubMed ID: 19089925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic value of IL10 and TNF alpha functional polymorphisms in premenopausal early-stage breast cancer patients.
    Korobeinikova E; Myrzaliyeva D; Ugenskiene R; Raulinaityte D; Gedminaite J; Smigelskas K; Juozaityte E
    BMC Genet; 2015 Jun; 16():70. PubMed ID: 26112140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of breast cancer susceptibility loci with patient characteristics, metastasis-free survival, and mRNA expression of the nearest genes.
    Riaz M; Berns EM; Sieuwerts AM; Ruigrok-Ritstier K; de Weerd V; Groenewoud A; Uitterlinden AG; Look MP; Klijn JG; Sleijfer S; Foekens JA; Martens JW
    Breast Cancer Res Treat; 2012 Jun; 133(3):843-51. PubMed ID: 21748294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of the prognostic role of a 94-single nucleotide polymorphisms risk score in early breast cancer in the SIGNAL/PHARE prospective cohort: no correlation with clinico-pathological characteristics and outcomes.
    Curtit E; Pivot X; Henriques J; Paget-Bailly S; Fumoleau P; Rios M; Bonnefoi H; Bachelot T; Soulié P; Jouannaud C; Bourgeois H; Petit T; Tennevet I; Assouline D; Mathieu MC; Jacquin JP; Lavau-Denes S; Darut-Jouve A; Ferrero JM; Tarpin C; Lévy C; Delecroix V; Trillet-Lenoir V; Cojocarasu O; Meunier J; Pierga JY; Kerbrat P; Faure-Mercier C; Blanché H; Sahbatou M; Boland A; Bacq D; Besse C; Thomas G; Deleuze JF; Pauporté I; Romieu G; Cox DG
    Breast Cancer Res; 2017 Aug; 19(1):98. PubMed ID: 28830573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sipa1 promoter polymorphism predicts risk and metastasis of lung cancer in Chinese.
    Xie C; Yang L; Yang X; Yang R; Li Y; Qiu F; Chen M; Fang W; Bin X; Deng J; Huang D; Liu B; Zhou Y; Lu J
    Mol Carcinog; 2013 Nov; 52 Suppl 1():E110-7. PubMed ID: 23661532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significant association between ERCC2 and MTHR polymorphisms and breast cancer susceptibility in Moroccan population: genotype and haplotype analysis in a case-control study.
    Hardi H; Melki R; Boughaleb Z; El Harroudi T; Aissaoui S; Boukhatem N
    BMC Cancer; 2018 Mar; 18(1):292. PubMed ID: 29544444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterogeneic expression of estrogen receptor between the primary tumor and the corresponding involved lymph nodes in patients with node-positive breast cancer and its implications in patient outcome.
    Iguchi C; Nio Y; Itakura M
    J Surg Oncol; 2003 Jun; 83(2):85-93. PubMed ID: 12772201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association of SIPA1 gene polymorphisms with breast cancer risk: evidence from published studies.
    Yi SM; Li GY
    Tumour Biol; 2014 Jan; 35(1):441-5. PubMed ID: 24006220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A genetic variant in p63 (rs17506395) is associated with breast cancer susceptibility and prognosis.
    Zhang N; Huo Q; Wang X; Chen X; Long L; Guan X; Jiang L; Ma T; Hu W; Yang Q
    Gene; 2014 Feb; 535(2):170-6. PubMed ID: 24316488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.